IMM 0.00% 15.5¢ immutep limited

New Report available

  1. 103 Posts.
    lightbulb Created with Sketch. 17

    COVID – 19 IMPACT ON IMMUNE CHECKPOINT INHIBITORS MARKET 2020 INDUSTRY TOP LEADERS: MERCK & CO., MERCK KGAA, NOVARTIS AG, PFIZER, ASTRAZENECA, IMMUTEP LIMITED

    Immune checkpoint inhibitor is a type of drug used in immunotherapy. Although traditional chemotherapeutic drugs remain the first-line option for treatment of most cancer types, targeted immune therapies are emerging as standard treatments for advanced-stage cancers. These drugs target cell surface checkpoint proteins to stimulate the recognition and destruction of cancer cells by the immune system.


    The global immune checkpoint inhibitors market is segmented based on type, application, and region. Based on type, the market is classified into CTLA-4 inhibitor, PD-1 inhibitor, PD-L1 inhibitor, and others. Based on application, it is categorized as lung cancer, bladder cancer, melanoma, hodgkin lymphoma, and others. Based on region, it is studied across North America Europe, Asia-Pacific, South America and Middle East and Africa.

    Get Sample copy of This Report @ https://www.orianresearch.com/request-sample/1244157

    This report focuses on Immune Checkpoint Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immune Checkpoint Inhibitors market size by analyzing historical data and future prospect.

    The key players profiled in the market include:-

    AstraZeneca PLC.
    Bristol-Myers Squibb Company
    Eli Lilly and Company
    Fortress Biotech, Inc.
    Hoffmann-La Roche Ltd.
    Immutep Limited
    Merck & Co., Inc.
    ….

    Global Immune Checkpoint Inhibitors Industry is spread across 121 pages, profiling 10 top companies and supported with tables and figures.

    Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/1244157

    On the basis of type, the market is split into:

    CTLA-4 Inhibitor
    PD-1 Inhibitor
    PD-L1 Inhibitor
    Other Types

    On the basis of application, the market is split into:

    Lung Cancer
    Bladder Cancer
    Melanoma
    Hodgkin Lymphoma
    Others

    Target Audience:

    Immune Checkpoint Inhibitors Manufacturers
    Traders, Importers, and Exporters
    Raw Material Suppliers and Distributors
    Research and Consulting Firms
    Government and Research Organizations
    Associations and Industry Bodies

    Order a Copy of Global Immune Checkpoint Inhibitors Market Report @ https://www.orianresearch.com/checkout/1244157


 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
0.000(0.00%)
Mkt cap ! $75.58M
Open High Low Value Volume
15.5¢ 16.0¢ 15.0¢ $85.39K 547.0K

Buyers (Bids)

No. Vol. Price($)
16 933721 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 689606 7
View Market Depth
Last trade - 15.58pm 10/07/2020 (20 minute delay) ?
(live)
Last
15.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
16.0¢ 16.0¢ 15.5¢ 145148
Last updated 15.58pm 10/07/2020 (live) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.